Custom Search
Diltiazem News
Biovail to Pay $24.6 Million to Settle Charges, Keep Federal Business
Biovail Pharmaceuticals, the U.S. subsidiary of Canada’s Biovail, has agreed to pay $24.6 million to settle criminal charges of improper marketing surrounding its commercial launch of Cardizem LA.
Hypertension drug reduces cocaine cravings
A U.S. study suggests diltiazem, used to treat hypertension, can also reduce cocaine cravings in a rat model.
Treatmenting Lysosomal Storage Diseases
A new study reports a possible breakthrough for treatment for some lysosomal storage diseases. The study finds two drugs -- diltiazem and verapamil -- could prove to be beneficial to patients.
Biovail Faces U.S. Investigation Over Cardizem
Biovail Corp said on Friday that it is being investigated by a U.S. Federal grand jury concerning the 2003 commercial launch of its Cardizem LA heart drug.
Cocaine-filled rock guitars seized at BWI
Drugs and rock ’n’ roll have always gone together — but not quite like this.